title: Contact Lenses: A Delivery Device for Stem Cells to Treat Corneal Blindness.
abstract: : Worldwide, 45 million people are blind. Corneal blindness is a major cause of visual loss, estimated to affect 10 million. For the most difficult to treat patients, including those with a disease called limbal stem cell deficiency, a donor corneal graft is not a viable option; thus, patients are treated with specialized stem cell grafts, which fail in a significant proportion (30 to 50%) of subjects. This unacceptable failure rate means there is a pressing need to develop minimally invasive, long-lasting, cost-effective therapies to improve patient quality of life and lessen the economic burden. Restoring vision in patients with severe corneal disease is the main focus of our research program; however, to achieve our goals and deliver the best quality stem cell therapy, we must first understand the basic biology of these cells, including their residence, the factors that support their long-term existence, markers to identify and isolate them, and carriers that facilitate expansion, delivery, and protection during engraftment. We recently achieved some of these goals through the discovery of stem cell markers and the development of a novel and innovative contact lens-based cell transfer technique that has been successfully trialed on patients with corneal blindness. Although several popular methodologies are currently available to nurture and transfer stem cells to the patients' ocular surface, contact lenses provide many advantages that will be discussed in this review article. The job for clinician-researchers will be to map precisely how these cells contribute to restoring ocular health and whether improvements in the quality of cells and the cell delivery system can be developed to reduce disease burden.
authors.affiliation: *BScHons(Med) †PhD School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia (both authors).
authors.forename: Samantha
authors.initials: S
authors.lastname: Bobba
authors.forename: Nick
authors.initials: N
authors.lastname: Di Girolamo
mesh_terms: D064987:Cell- and Tissue-Based Therapy / Q000379:methods*; D003228:Conjunctiva / Q000166:cytology; D003263:Contact Lenses, Hydrophilic; D003316:Corneal Diseases / Q000628:therapy*; D016503:Drug Delivery Systems; D004847:Epithelial Cells / Q000166:cytology; D019573:Epithelium, Corneal / Q000166:cytology*; D048091:Guided Tissue Regeneration; D006801:Humans; D016850:Limbus Corneae / Q000166:cytology*; D013234:Stem Cells / Q000166:cytology*